Better science
doesn’t need a cage.
Cell cultures, human tissue, computer models and human volunteer studies are already replacing animal experiments across toxicology, neuroscience and drug development — and outperforming them.
Replacing animal tests doesn’t slow medicine down. It sharpens it.
Non-animal methods are advancing quickly across toxicity testing, neuroscience and drug development. The science is often ready before the rules are: one of the ongoing jobs for researchers and regulators alike is pushing validated alternatives through the bureaucracy that keeps animal tests as the default.
Ten countries account for the bulk of animal use
Estimated annual animal use by country, in millions — the most recent reliable global comparison available.
The switch to human cell-culture research is a major reason mouse breeding and animal experiments are falling again in Great Britain, after decades of steady decline since the 1970s peak.
A closer look at one year of official figures
Only a tenth of these procedures were legally required — the rest were run by choice.
What’s already replacing the animal in the lab
Each of these approaches is in active use today — cheaper and quicker to run, and in head-to-head studies, often more accurate at predicting how a human will actually respond.
01 — Cell cultures
Miniature organs, grown to order
Human and animal cells are grown in the lab and coaxed into 3D structures — “organs-on-chips” that mimic the lung, heart, kidney and gut, working toward a full human-on-a-chip. They already underpin research into cancer, sepsis, kidney disease and AIDS, plus routine chemical safety and vaccine testing.
02 — Human tissue
Real human biology, ethically sourced
Tissue from volunteers, surgical procedures and post-mortem donation gives a far more relevant model than an animal ever could. Reconstituted human skin and eye tissue already replace the classic rabbit irritation assay; donated brain tissue has reshaped what we know about MS and Parkinson’s.
03 — Computer models
Simulating the body, digitally
Models of the heart, lungs, kidneys, skin, gut and skeleton now run virtual experiments against existing data. Data-mining tools predict how a new chemical will behave by comparing it with compounds already understood — reducing animal use while speeding discovery up.
04 — Human volunteers
Studying people, safely
Brain imaging tracks neurological disease in real time. Microdosing measures how a drug behaves using a fraction of a normal dose. Volunteer studies on nutrition, addiction and pain add something no animal model can: a person who can describe what they’re experiencing.
Where it’s been measured, alternatives predict humans better
Shellfish toxin testing tells the same story a different way: the live-mouse assay has now been fully replaced by an analytical chemistry method that protects people better than the animal test ever did.
Some of medicine’s biggest turning points started with people, not animals
1906 — Alzheimer’s disease first described
Alois Alzheimer identified the disease’s defining features by examining brain tissue from patients after death, not from any animal model.
Aspirin’s pain relief, confirmed on itself
After an accidental discovery relieved a patient’s toothache, a German chemist tested the effect on himself directly.
Laughing gas anaesthesia
Discovered when someone cut their leg without noticing while under its influence; an American dentist confirmed the effect on himself during a tooth extraction.
Smoking linked to cancer
Large human population studies made the connection. Smoking doesn’t reliably cause cancer in mice and rats, so an animal model would have missed it.
The real cause of stomach ulcers
An Australian doctor drank a culture of bacteria, became ill, and cured himself with antibiotics — proving the bacterial cause directly.
Deep Brain Stimulation targeting
Brain surgery in Parkinson’s patients pinpointed the best electrode placement decades before the same finding was reported in monkeys.
See the alternatives at work
Our documentary walks through the labs and researchers building the replacement for animal testing, one method at a time.
Even the biggest names in testing are moving
Market research into the global in-vitro toxicity testing industry points to the same driver everywhere: alternatives are faster, cheaper, and easier to defend to regulators and the public alike — and that’s dragging even long-time animal-testing contractors toward in-vitro methods.
Regulatory pressure
Advocacy groups keep pushing regulators to accept validated non-animal methods in place of animal data, closing the gap between what science can already do and what the rules still require.
Cost and speed
In-vitro methods are consistently quicker to run and cheaper to scale than animal studies, which is reshaping procurement decisions across the industry.
Public accountability
Investigations into animal welfare inside testing contractors have made the reputational cost of animal use harder to ignore, accelerating the move toward alternatives.
In vitro testing
Lab-grown human cells and tissue predict how a real person will respond to a chemical or drug — more precisely, and more humanely, than an animal model can.
Mineral assay
Contract labs once built around animal testing, including Covance and Charles River Laboratories, are now among the leaders developing in-vitro assay methods.
Pharmaceutical research
Both companies have also faced scrutiny over past use and treatment of nonhuman primates — part of why the shift toward validated alternatives matters.
The team
Margaret Anderson
Head of Laboratory Department
Mark Anthony
Senior Pathologist
Samantha Wood
Laboratory Technician